< Back to previous page
Researcher
Frédéric Amant
- Disciplines:Gynaecology
Affiliations
- Gynaecological Oncology (Division)
Responsible
From1 Mar 2006 → Today - Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 60
- Overcoming resistance to anti-PD1 blockade in uterine leiomyosarcomasFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Post-mortem tissue biobanking to illuminate end-stage ovarian cancer disease (ATLASOvCANCER)From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: BOF - ZAP BOF mandates
- Advisory Board Cancer Infertility Pregnancy (ABCIP)From1 Jan 2023 → 31 Dec 2023Funding: Other federal public and semi-governmental institutions
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Impact of prenatal exposure to cancer treatment during pregnancy and of chemotherapy for breast cancer on the brains: a multimodal MR imaging studyFrom1 Dec 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Defining the role of the tumor microenvironment in treatment resistance of OVArian cancer through patient-Derived EXplants (OVADEX)From1 Sep 2022 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
Publications
1 - 10 of 577
- Sentinel lymph node biopsy for breast cancer during pregnancy: A comprehensive update(2024)
Authors: Frédéric Amant
- ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.(2024)
Authors: Frédéric Amant, Ignace Vergote
Pages: 248 - 266 - Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database(2024)
Authors: Joren Vanbraband, Frédéric Amant
Pages: 70 - 78 - Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI(2023)
Authors: Vincent Vandecaveye, Elleke Dresen, Els Van Nieuwenhuysen, Thaïs Baert, Frédéric Amant, Toon Van Gorp
Pages: 1890 - 1897 - Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk(2023)
Authors: Frédéric Amant
Pages: 1931 - 1944 - Non-invasive prenatal testing: when results suggests maternal cancer(2023)
Authors: Liesbeth Lenaerts, Miel Theunis, Frédéric Amant, Joris Vermeesch
Pages: 285 - 295 - Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab(2023)
Authors: Joosje Heimovaara, Frédéric Amant
Pages: 1790 - 1796 - European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors(2023)
Authors: Frédéric Amant, Sileny Han
Pages: 1621 - 1626 - A novel flavonol glycoside and six derivatives of quercetin and kaempferol from Clematis flammula with antioxidant and anticancer potentials(2023)
Authors: Frédéric Amant
- High accumulation of nivolumab in human breast milk: A case report(2023)
Authors: Frédéric Amant